Darotropium bromide(GSK233705, GSK233705B) is an inhaled long-acting muscarinic antagonist under development for the treatment of chronic obstructive pulmonary disease (COPD).GSK233705 showed bronchiectasis activity and was well tolerated.

850607-58-8

C24H29BrN2

425.4

GSK233705B;GSK 233705;GSK-233705;GSK 233705B;GSK233705;GSK-233705B;Darotropium bromide

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years